Boston Scientific insider trading
Health Care · Strong buyingShare price and insider trades
Valuation, profit and volume
Pick score 47/100Summary
Over the past 12 months, 5 Boston Scientific insiders reported open-market purchases totaling $10.0M, while 4 insiders reported sales totaling $24.3M. The most recent cluster buy began on Jul 31, 2026, when 3 insiders bought a combined $9.4M. 9 of 9 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
News and SEC events
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales. 114 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 26SEC | Susan E MoranoDirector | Buy | 2,040 | $49.22 | $100K | -13.9% | — |
| Aug 7SEC | David C HabigerDirector | Buy | 2,100 | $47.59 | $100K | -10.9% | — |
| Aug 5SEC | Michael F MahoneyCEO, President | Buy | 186,240 | $48.33 | $9.0M | -12.3% | — |
| Aug 5SEC | David C HabigerDirector | Buy | 1,042 | $48.07 | $50K | -11.8% | — |
| Aug 5SEC | David C HabigerDirector | Buy | 140 | $48.59 | $7K | -12.7% | — |
| Aug 3SEC | Edward J LudwigDirector | Buy | 5,000 | $45.48 | $227K | -6.8% | — |
| May 21SEC | Edward J LudwigDirector | Buy | 3,580 | $56.68 | $203K | -25.2% | — |
| May 21SEC | David C HabigerDirector | Buy | 2,250 | $55.92 | $126K | -24.2% | — |
| May 21SEC | David C HabigerDirector | Buy | 2,200 | $56.95 | $125K | -25.5% | — |
| May 21SEC | Cheryl PegusDirector | Buy | 1,770 | $56.49 | $100K | -24.9% | — |
| Feb 3SEC | Michael F MahoneyCEO, President | Sell Plan | 159,701 | $93.49 | $14.9M | -54.6% | — |
| Feb 3SEC | Michael F MahoneyCEO, President | Sell Plan | 1,200 | $94.06 | $113K | -54.9% | — |
| Dec 2SEC | Arthur C ButcherEvp& Grp Pres, Medsurg & Apac | Sell Plan | 17,313 | $101.55 | $1.8M | -58.2% | — |
| Nov 6SEC | Ellen M ZaneDirector | Sell Plan | 12,891 | $98.28 | $1.3M | -56.9% | — |
| Nov 4SEC | Joseph Michael FitzgeraldEvp & Group Pres, Cardiology | Sell Plan | 29,472 | $99.14 | $2.9M | -57.2% | — |
| Nov 4SEC | Joseph Michael FitzgeraldEvp & Group Pres, Cardiology | Sell Plan | 16,928 | $99.76 | $1.7M | -57.5% | — |
| Nov 4SEC | Joseph Michael FitzgeraldEvp & Group Pres, Cardiology | Sell Plan | 3,600 | $100.75 | $363K | -57.9% | — |
| Oct 28SEC | Ellen M ZaneDirector | Sell Plan | 9,990 | $101.13 | $1.0M | -58.1% | — |
| Oct 28SEC | Ellen M ZaneDirector | Sell Plan | 2,901 | $102.24 | $297K | -58.5% | — |
Insiders at Boston Scientific
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Michael F MahoneyCEO, President | $9.0M | $15.0M | Aug 5, 2026 | — |
| Joseph Michael FitzgeraldEvp & Group Pres, Cardiology | — | $5.0M | Aug 3, 2026 | — |
| Ellen M ZaneDirector | — | $2.6M | May 11, 2026 | — |
| Arthur C ButcherEvp& Grp Pres, Medsurg & Apac | — | $1.8M | May 4, 2026 | — |
| Edward J LudwigDirector | $430K | — | Aug 3, 2026 | — |
| David C HabigerDirector | $408K | — | Aug 7, 2026 | — |
| Susan E MoranoDirector | $100K | — | Aug 26, 2026 | — |
| Cheryl PegusDirector | $100K | — | May 21, 2026 | — |
| Padraig Andrew O'connorEvp, Global Operations | — | — | Sep 3, 2026 | — |
| Emily WoodworthSvp, Global Controller And Cao | — | — | Aug 12, 2026 | — |
| Jonathan MonsonCFO | — | — | Aug 11, 2026 | — |
| Jessica L MegaDirector | — | — | May 11, 2026 | — |
| Christophe Pierre WeberDirector | — | — | May 11, 2026 | — |
| David S WichmannDirector | — | — | May 11, 2026 | — |
| Vance R BrownEvp, Gc And Corp. Secretary | — | — | Feb 18, 2026 | — |
| Miriam O'sullivanSvp, Chief Hr Officer | — | — | Feb 18, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about BSX insiders
Are Boston Scientific insiders buying BSX stock?
In the past 12 months, 5 insiders reported open-market purchases of BSX worth $10.0M. The latest was Director Susan E Morano bought $100K of BSX at $49.22 — first open-market purchase in our records.
Are Boston Scientific insiders selling BSX stock?
4 insiders reported sales worth $24.3M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.